NFKB1 and cancer: Their aberrant expression has been shown to play an important role in many cancer-related signaling molecules/pathways, such as Notch, mTOR, NF-kb, and the Wnt/β-catenin pathway, and can affect various malignant phenotypes in cancer cells (Chi et al., 2019; Chen et al., 2020).